Capricor Therapeutics, Inc.

CAPR · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$19,510$23,241$28,795$11,287
Short-Term Investments$79,056$99,559$115,983$140,229
Receivables$59$60$60$10,368
Inventory$0$0$0$0
Other Curr. Assets$2,327$1,266$1,414$1,501
Total Curr. Assets$100,952$124,127$146,251$163,385
Property Plant & Equip (Net)$24,998$8,934$7,262$6,874
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$489$508$253$222
Total NC Assets$25,487$9,442$7,515$7,096
Other Assets$0$0$0$0
Total Assets$126,438$133,569$153,766$170,481
Liabilities
Payables$2,719$4,812$5,254$8,181
Short-Term Debt$120$850$842$835
Tax Payable$0$0$0$0
Deferred Revenue$12,000$12,000$12,000$0
Other Curr. Liab.$13,309$10,735$4,241$12,010
Total Curr. Liab.$28,148$28,397$22,337$21,026
LT Debt$14,423$195$407$616
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$3,376$3,376
Total NC Liab.$14,423$195$3,784$3,993
Other Liabilities$0$0$0$0
Cap. Leases$14,543$1,044$1,249$1,451
Total Liabilities$42,571$28,592$26,121$25,019
Equity
Pref Stock$0$0$0$0
Common Stock$46$46$46$46
Retained Earnings-$274,708-$250,137-$224,226-$199,835
AOCI$844$1,388$1,812$1,027
Other Equity$357,685$353,681$350,014$344,224
Total Equity$83,867$104,977$127,645$145,462
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$126,438$133,569$153,766$170,481
Net Debt-$4,968-$22,197-$27,545-$9,836